SCHEMBL18558552

SCHEMBL18558552

COc1ccccc1CN/C(=N/C(=O)c1ccc(C(F)(F)F)cc1)Nc1cc(C(F)(F)F)n[nH]1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.44
HTT P42858 2/20 0.43
RXFP1 Q9HBX9 1/20 0.41
PPARD Q03181 2/20 0.41
PPARA Q07869 2/20 0.41
CSNK1D P48730 1/20 0.40
ROCK2 O75116 3/20 0.40
PRKCA P17252 1/20 0.40
GRK2 P25098 1/20 0.40
ROCK1 Q13464 2/20 0.40
KDM4E B2RXH2 2/20 0.40
THRB P10828 1/20 0.40
ALDH1A1 P00352 2/20 0.39
MAPT P10636 1/20 0.39
NPC1 O15118 1/20 0.39
GAA P10253 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9921105 0.81 HDAC6 (0.37) HDAC1HTTMAPTLMNA
SCHEMBL17088583 0.80 EPHX2 (0.46) HDAC1ROCK2ROCK1GAA
SCHEMBL18558219 0.80 MAPT (0.45) RXFP1KDM4EMAPTNPC1GAA
SCHEMBL18557724 0.80 ROCK2 (0.43) ROCK2ROCK1MAPT
SCHEMBL18557578 0.79 ROCK2 (0.45) ROCK2ROCK1KDM4ETHRB
SCHEMBL9921034 0.77 HDAC6 (0.39)
SCHEMBL17088582 0.77 EPHX2 (0.45) HDAC1ROCK2ROCK1
SCHEMBL9920695 0.77 HDAC6 (0.37) HTTLMNA
SCHEMBL9920910 0.77 HTT (0.41) HTTKDM4EALDH1A1MAPTLMNA
SCHEMBL9920696 0.77 NPSR1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9580388-B2 Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2017-02-28 US disclosed